202 related articles for article (PubMed ID: 20332212)
1. Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.
Bruni-Cardoso A; Johnson LC; Vessella RL; Peterson TE; Lynch CC
Mol Cancer Res; 2010 Apr; 8(4):459-70. PubMed ID: 20332212
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Thiolloy S; Halpern J; Holt GE; Schwartz HS; Mundy GR; Matrisian LM; Lynch CC
Cancer Res; 2009 Aug; 69(16):6747-55. PubMed ID: 19679556
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis.
Frieling JS; Li T; Tauro M; Lynch CC
Neoplasia; 2020 Oct; 22(10):511-521. PubMed ID: 32896761
[TBL] [Abstract][Full Text] [Related]
5. Osteoclasts are important for bone angiogenesis.
Cackowski FC; Anderson JL; Patrene KD; Choksi RJ; Shapiro SD; Windle JJ; Blair HC; Roodman GD
Blood; 2010 Jan; 115(1):140-9. PubMed ID: 19887675
[TBL] [Abstract][Full Text] [Related]
6. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
7. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
11. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.
Thiolloy S; Edwards JR; Fingleton B; Rifkin DB; Matrisian LM; Lynch CC
PLoS One; 2012; 7(1):e29862. PubMed ID: 22238668
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
14. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
[TBL] [Abstract][Full Text] [Related]
15. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.
Andersen TL; del Carmen Ovejero M; Kirkegaard T; Lenhard T; Foged NT; Delaissé JM
Bone; 2004 Nov; 35(5):1107-19. PubMed ID: 15542036
[TBL] [Abstract][Full Text] [Related]
16. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.
Ortega N; Wang K; Ferrara N; Werb Z; Vu TH
Dis Model Mech; 2010; 3(3-4):224-35. PubMed ID: 20142327
[TBL] [Abstract][Full Text] [Related]
17. Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Yılmaz Akçay E; Tepeoğlu M; Börcek P; Dirim A
Ann Diagn Pathol; 2020 Apr; 45():151480. PubMed ID: 32106037
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
Dong Z; Bonfil RD; Chinni S; Deng X; Trindade Filho JC; Bernardo M; Vaishampayan U; Che M; Sloane BF; Sheng S; Fridman R; Cher ML
Am J Pathol; 2005 Apr; 166(4):1173-86. PubMed ID: 15793297
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones.
Engsig MT; Chen QJ; Vu TH; Pedersen AC; Therkidsen B; Lund LR; Henriksen K; Lenhard T; Foged NT; Werb Z; Delaissé JM
J Cell Biol; 2000 Nov; 151(4):879-89. PubMed ID: 11076971
[TBL] [Abstract][Full Text] [Related]
20. Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
Nabha SM; Bonfil RD; Yamamoto HA; Belizi A; Wiesner C; Dong Z; Cher ML
Clin Exp Metastasis; 2006; 23(7-8):335-44. PubMed ID: 17136575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
